Skip to content
metaboliq

GLP-1 side effects: what is common, what is serious, and protecting muscle

Most side effects of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) are in the stomach and gut, and are worst in the first weeks and after each step up. A few are serious and need a doctor at once. Muscle is lost along with fat unless the plan protects it.

Approved in India
Mounjaro, Wegovy and the generic semaglutide brands, each for its own labelled use.
Most common
Nausea, diarrhoea, vomiting, constipation, indigestion.
When
Mostly in the first weeks, and after each step up in strength.
Serious, rare
Pancreatitis, gallbladder problems, dehydration, allergic reaction.
Who decides
A doctor, who also decides when to slow down or stop.

Why the stomach is affected

Semaglutide and tirzepatide slow how fast the stomach empties. That is part of how they increase fullness, and it is also why nausea, burping, bloating and constipation are the most common complaints.

Starting at a low strength and stepping up slowly is the main way the labels limit them. Smaller meals, stopping at the first sign of fullness, and enough water help too.

Sources: [1], [3]

The serious ones

The labels list pancreatitis, gallbladder problems including gallstones, kidney strain from dehydration, low blood sugar when combined with insulin or a sulfonylurea, and allergic reactions. For semaglutide, NAION, a sudden painless loss of vision in one eye, is listed as very rare.

Sources: [1], [2], [3]

Hair, skin and the face

Hair thinning and a thinner-looking face are reported by people whose body weight falls quickly. They follow the speed of the change and low protein intake more than any one product, which is one more reason protein matters.

Muscle loss, measured

In the STEP 1 body-composition substudy, roughly 40% of the total body weight lost was lean mass. Protein at every meal, strength training two or three times a week, and measuring body composition are how a plan protects it.

Sources: [4]

Who decides, and how it is started

It is prescription-only in India, and a doctor decides whether it fits you after reading your history, your blood tests and anything else you take.

It is started at a low strength and stepped up every four weeks or so, because stepping up slowly is what keeps the stomach side effects manageable.

Sold outside an authorised pharmacy, a pen can be fake, wrongly stored or the wrong strength; the regulator has asked states to keep these products to authorised channels and their approved uses.

Sources: [5]

What happens when it is stopped

These work while they are taken. One year after semaglutide was stopped in the STEP 1 extension, people had regained about two-thirds of what they had lost; in SURMOUNT-4, people switched from tirzepatide to placebo regained about 14% of body weight.

That is why the habits built alongside treatment, and a plan for maintenance, matter as much as the treatment itself.

Sources: [6], [7]

Side effects

Common, and usually easing with time

  • Nausea, most often in the first weeks and after each step up.
  • Diarrhoea or constipation.
  • Vomiting, indigestion, burping and bloating.
  • Feeling full early, and less appetite.
  • Tiredness, and headache.

Serious, and rare

  • Pancreatitis: severe, lasting pain in the upper abdomen that may spread to the back, with or without vomiting.
  • Gallbladder problems, including gallstones, which are more likely when body weight falls quickly.
  • Dehydration from vomiting or diarrhoea, which can strain the kidneys.
  • Low blood sugar, mainly when it is combined with insulin or a sulfonylurea.
  • Allergic reactions, rare but serious.
  • A history of medullary thyroid cancer or MEN 2 in you or your family is a reason it is not used.
  • NAION, a sudden painless loss of vision in one eye, listed as a very rare side effect of semaglutide.

Stop and get medical help at once for severe abdominal pain, repeated vomiting, signs of an allergic reaction, or sudden changes in vision. Tell the doctor about pregnancy plans first: these are not used in pregnancy.

Questions people ask

How long do Ozempic and Mounjaro side effects last?

For most people the stomach side effects ease within days to weeks, and return briefly after each step up. If they do not ease, the doctor can hold or lower the strength.

What should I eat to reduce nausea?

Smaller meals, eaten slowly, stopping at the first sign of fullness; less fried and very fatty food; and enough water through the day.

When should I call a doctor straight away?

For severe or lasting pain in the upper abdomen, repeated vomiting, signs of an allergic reaction, or any sudden change in vision.

Every source, in full

  1. [1] Wegovy: EPAR and product information

    European Medicines Agency, 2025. The full label for semaglutide 2.4 mg: approved for chronic weight management, with its warnings and side effects.

    Read the source
  2. [2] Ozempic: EPAR and product information

    European Medicines Agency, 2025. The full label: Ozempic is approved for adults with type 2 diabetes, with its warnings and the side effects seen in trials.

    Read the source
  3. [3] Mounjaro: EPAR and product information

    European Medicines Agency, 2025. The full label: approved uses, how it is started and stepped up, warnings, and the side effects seen in trials with how often each occurred.

    Read the source
  4. [4] Body composition changes with semaglutide in the STEP 1 body-composition substudy, reviewed

    Postgraduate Medicine, 2022. In the STEP 1 body-composition substudy, roughly 40% of the total body weight lost was lean mass rather than fat.

    Read the source
  5. [5] DCGI letter to states on the sale and promotion of GLP-1 receptor agonists, 27 March 2026

    Central Drugs Standard Control Organisation, via Medical Dialogues, 2026. Directs states to ensure these products are sold only through authorised channels, strictly in line with their approved indications and labelling.

    Read the source
  6. [6] Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension

    Diabetes, Obesity and Metabolism, 2022. One year after semaglutide was stopped, participants had regained about two-thirds of the body weight they had lost.

    Read the source
  7. [7] Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4)

    JAMA, 2024. After 36 weeks on tirzepatide, people switched to placebo regained about 14% of body weight by week 88; people who continued went on to a further 5.5% reduction.

    Read the source

Talk to a doctor about your own results.

A registered doctor reads your blood report and your history, and decides with you what comes next.